MT 007B
Alternative Names: MT-007BLatest Information Update: 05 Feb 2024
At a glance
- Originator Merakris Therapeutics
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified
Most Recent Events
- 19 Dec 2023 Early research in Unspecified in USA (unspecified route) (Merakris Therapeutics pipeline, December 2023)